Posts in tag

biotechnology company


What does Metacrine do? Metacrine, is a privately held biotechnology company which is focused on targeting metabolic disease through advances in endocrine research. The company licensed from Howard Hughes Medical Institute Investigator at the Salk Institute and from the laboratory of Dr.Ronald Evans, a world leader in nuclear home receptors. This biotech company leverages 2 …

What does Juventas Therapeutics do? Juventas Therapeutics, is a clinical stage biotechnology company which develops regenerative therapies to treat life threatening diseases. This private clinical stage biotech company is developing a pipeline of regenerative therapies to treat life threatening diseases. It has exclusive license from the Cleveland clinic, and transitioned from its platform from concept …

What does InCarda Therapeutics do? InCarda Therapeutics, formerly known as Pleiades Cardio-Therapeutics is a privately held biotechnology company which focuses on developing and commercializing therapies for acute cardiovascular condition through inhalation route. It develops transformative therapies for patients for use in the initial moments of symptoms experiences in acute cardiovascular conditions. InCarda Therapeutics develops an …

What does True North Therapeutics do? True North Therapeutics, is a pioneering biotechnology company which selectively inhibits the complement pathway for diseases with high unmet clinical necessity. True North Therapuetics’s monoclonal antibody, TNT009, targets the Classical Complement Pathway, enabling the selective inhibition of downstream phagocytosis, cell lysis and inflammation. This biotech company is currently focusing …

What does Scholar Rock? Scholar Rock, is a biotechnology company which is focused on discovering and developing drugs which selectively targets supra cellular activation of growth factors in the disease micro-environment. The company is discovering and developing a new class of biological therapies. The company focuses on the discovering and developing of novel biological therapeutics. …

4